These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 33566579)
1. Influence of Lipid Membranes on α-Synuclein Aggregation. Kurochka AS; Yushchenko DA; Bouř P; Shvadchak VV ACS Chem Neurosci; 2021 Mar; 12(5):825-830. PubMed ID: 33566579 [TBL] [Abstract][Full Text] [Related]
2. The effect of fluorescent labeling on α-synuclein fibril morphology. Mučibabić M; Apetri MM; Canters GW; Aartsma TJ Biochim Biophys Acta; 2016 Oct; 1864(10):1419-27. PubMed ID: 27475048 [TBL] [Abstract][Full Text] [Related]
3. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation. Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854 [TBL] [Abstract][Full Text] [Related]
4. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease. Galvagnion C J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142 [TBL] [Abstract][Full Text] [Related]
7. Direct Visualization of Model Membrane Remodeling by α-Synuclein Fibrillization. Chaudhary H; Subramaniam V; Claessens MMAE Chemphyschem; 2017 Jun; 18(12):1620-1626. PubMed ID: 28370874 [TBL] [Abstract][Full Text] [Related]
8. Rationally Designed Protein-Based Inhibitor of α-Synuclein Fibrillization in Cells. Priss A; Afitska K; Galkin M; Yushchenko DA; Shvadchak VV J Med Chem; 2021 May; 64(10):6827-6837. PubMed ID: 33970620 [TBL] [Abstract][Full Text] [Related]
9. The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of Sternke-Hoffmann R; Peduzzo A; Bolakhrif N; Haas R; Buell AK Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183378 [TBL] [Abstract][Full Text] [Related]
10. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution. Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954 [TBL] [Abstract][Full Text] [Related]
11. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein. Galvagnion C; Brown JW; Ouberai MM; Flagmeier P; Vendruscolo M; Buell AK; Sparr E; Dobson CM Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7065-70. PubMed ID: 27298346 [TBL] [Abstract][Full Text] [Related]
12. N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates. Bell R; Thrush RJ; Castellana-Cruz M; Oeller M; Staats R; Nene A; Flagmeier P; Xu CK; Satapathy S; Galvagnion C; Wilson MR; Dobson CM; Kumita JR; Vendruscolo M Biochemistry; 2022 Sep; 61(17):1743-1756. PubMed ID: 35944093 [TBL] [Abstract][Full Text] [Related]
13. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research. Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956 [TBL] [Abstract][Full Text] [Related]
17. Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration. Ziaunys M; Sakalauskas A; Mikalauskaite K; Smirnovas V Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830264 [TBL] [Abstract][Full Text] [Related]